Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992

Tissue Antigens

Volumn 42, Issue 1, 1993, Pages 45-54

  Pouletty, Philippe ^a   Ferrone, Soldano ^b   Amesland, Française ^c   Cohen, Nadine ^d   Westhoff, Ulriko ^a   Charron, Dominique ^c   Shimizu, Robert M ^a   Grosse‐Wilde, Hans ^e  

^a GENZYME CORPORATION   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c SAINT LOUIS HOSPITAL   (France)

^d FONDATION JEAN DAUSSET CEPH   (France)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

soluble HLA HLA ELISA monoclonal antibody standard transfectant

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN DETECTION; CHIMERA; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOASSAY; INTERNATIONAL COOPERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STANDARDIZATION; TECHNIQUE; WORKSHOP;

ALLELES; ANIMAL; ANTIBODIES, MONOCLONAL; CHIMERA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FRANCE; HLA ANTIGENS; HUMAN; LABORATORIES; MICE; PHENOTYPE; QUESTIONNAIRES; REFERENCE STANDARDS; SOLUBILITY;

EID: 0027275888     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1993.tb02166.x     Document Type: Article

References (25)

1. Summary of serum‐soluble HLA class I antigen component
2. Soluble class I antigens (sHLA) in CSF and serum of patients with HIV infection
3. Soluble class I antigens in Serum and CSF of patient with varicella‐zoster virus meningitis
4. Soluble class I concentrations and GvHD after allogeneic marrow transplantation
5. Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor
6. Soluble HLA class I serum concentrations increase with transplant‐related complications after liver transplantation
7. Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients
8. Biologic and chemical characterization of HLA antigens in human serum
9. Secretion of HLA‐A and ‐B antigens via an alternative RNA splicing pathway
10. Biochemical complexity of serum HLA class I molecules
11. Modulation by interferons of HLA antigen, high‐molecular‐weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential
12. Enhanced serum levels of soluble HLA class I molecules induced by treatment with recombinant interferon‐gamma (IFN‐gamma)
13. Soluble CD4, CD8 and HLA molecules in commercial immunoglobulin preparations
14. Immunochemical analysis of a recombinant, genetically engineered, secreted HLA‐A2/Q10b fusion protein
15. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain
16. sHLA‐STAT™ Class I. an ELISA for Quantitation of HLA Antigens in Serum
17. Distribution of “free” and HLA‐associated human β‐2‐microglobulin in some plasma membranes and biological fluids
18. Evaluation of two sources of soluble HLA antigens — Platelets and serum
19. Association between HLA phenotype and HLA concentration in plasma or platelets
20. A double determinant immunoassay for HLA class I typing using serum as an antigen source
21. Anti‐HLA‐B7, B27, Bw42, Bw55, Bw56, Bw67, Bw73 monoclonal antibodies: Specificity, idiotypes, and application for a double determinant immunoassay
22. Typing of serum soluble HLA‐B27 antigen by ELISA
23. Quantitation of soluble HLA class II molecules by an enzyme‐linked immunosorbent assay
24. Production and characterization of DR zenoantisera: Use for detection of serum DR antigens
25. Are soluble monocyte‐derived HLA class II molecules candidates for immunosuppressive activity